Advantages and disadvantages of using intravenous tissue Plasminogen activator as salvage therapy for inoperable HeartWare thrombosis

Robyn Basken, Charles M. Bazzell, Richard Smith, Rajesh Janardhanan, Zain I Khalpey

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Device thrombosis is a devastating complication of left ventricular assist devices. The definitive treatment has been device exchange or explant. Evidence of increasing morbidity and mortality with device exchange has shifted strategies toward conservative management. In this report, we detail the use of thrombolytics as salvage therapy in a patient with an occlusive HeartWare ventricular assist device (HeartWare Inc., Framingham, MA) thrombus, resulting in long-term survival without further intervention.

Original languageEnglish (US)
Pages (from-to)443-446
Number of pages4
JournalJournal of Cardiac Surgery
Volume32
Issue number7
DOIs
StatePublished - Jul 1 2017
Externally publishedYes

ASJC Scopus subject areas

  • Surgery
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Advantages and disadvantages of using intravenous tissue Plasminogen activator as salvage therapy for inoperable HeartWare thrombosis'. Together they form a unique fingerprint.

  • Cite this